Biomedical Engineering Reference
In-Depth Information
32. Goldman MP, Sadick NS, Weiss RA. Treatment of spider veins with the
595 nm pulsed-dye laser. J Am Acad Dermatol 2000; 42: 849-50.
33. Goldman MP, Bennett RG. Treatment of telangiectasia: a review. J Am
Acad Dermatol 1987; 17: 167-82.
34. Goldman M. Sclerotherapy: Treatment of Varicose and Telangiectatic
Leg Veins, 2nd edn. Sr. Louis: CV Mosby, 1995.
35. Raulin C, Weiss RA, Schonermark MP. Treatment of essential telangi-
ectasias with an intense pulsed light source (PhotoDerm VL). Derma-
tol Surg 1997; 23: 941-5; discussion 945-946.
36. Schmidt N, Gans E. Deodex and rosacea I: the prevalence and numbers
of Demodex mites in rosacea. Cosmet Dermatol 2004; 17: 497-502.
37. Prieto VG, Sadick NS, Lloreta J, Nicholson J, Shea CR. Effects of intense
pulsed light on sun-damaged human skin, routine, and ultrastructural
analysis. Lasers Surg Med 2002; 30: 82-5.
38. Dahl MV, Ross AJ, Schlievert PM. Temperature regulates bacterial pro-
tein production: possible role in rosacea. J Am Acad Dermatol 2004;
50: 266-72.
39. Baglieri F, Scuderi G. Treatment of recalcitrant granulomatous rosacea
with ALA-PDT: report of a case. Indian J Dermatol Venereol Leprol
2011; 77: 536.
40. Menezes N, Moreira A, Mota G, Baptista A. Quality of life and rosacea:
pulsed dye laser impact. J Cosmet Laser Ther 2009; 11: 139-41.
41. Laube S, Lanigan SW. Laser treatment of rosacea. J Cosmet Dermatol
2002; 1: 188-95.
42. Tan SR, Tope WD. Pulsed dye laser treatment of rosacea improves ery-
thema, symptomatology, and quality of life. J Am Acad Dermatol 2004;
51: 592-9.
43. Lowe NJ, Behr KL, Fitzpatrick R, Goldman M, Ruiz-Esparza J. Flash
lamp pumped dye laser for rosacea-associated telangiectasia and ery-
thema. J Dermatol Surg Oncol 1991; 17: 522-5.
44. Jasim ZF, Woo WK, Handley JM. Long-pulsed (6-ms) pulsed dye laser
treatment of rosacea-associated telangiectasia using subpurpuric clini-
cal threshold. Dermatol Surg 2004; 30: 37-40.
45. Berg M, Edstrom DW. Flashlamp pulsed dye laser (FPDL) did not cure
papulopustular rosacea. Lasers Surg Med 2004; 34: 266-8.
46. Mark KA, Sparacio RM, Voigt A, Marenus K, Sarnoff DS. Objective and
quantitative improvement of rosacea-associated erythema after intense
pulsed light treatment. Dermatol Surg 2003; 29: 600-4.
47. Schroeter CA, Haaf-von Below S, Neumann HA. Effective treatment of
rosacea using intense pulsed light systems. Dermatol Surg 2005; 31:
1285-9.
48. Taub AF. Treatment of rosacea with intense pulsed light. J Drugs Der-
matol 2003; 2: 254-9.
49. Stamatas GN, Kollias N. Blood stasis contributions to the perception
of skin pigmentation. J Biomed Opt 2004; 9: 315-22.
50. Behroozan DS, Goldberg LH, Glaich AS, Dai T, Friedman PM. Frac-
tional photothermolysis for treatment of poikiloderma of Civatte.
Dermatol Surg 2006; 32: 298-301.
51. Tierney EP, Hanke CW. Treatment of Poikiloderma of Civatte with
ablative fractional laser resurfacing: prospective study and review of
the literature. J Drugs Dermatol 2009; 8: 527-34.
52. Weiss RA, Goldman MP, Weiss MA. Treatment of poikiloderma of
Civatte with an intense pulsed light source. Dermatol Surg 2000; 26:
823-7; discussion 828.
53. Goldman MP, Weiss RA. Treatment of poikiloderma of Civatte on the
neck with an intense pulsed light source. Plast Reconstruct Surg 2001;
107: 1376-81.
54. Willenberg T, Baumgartner I. Vascular birthmarks. Vasa 2008; 37:
5-17.
55. Pasyk KA, Wlodarczyk SR, Jakobczak MM, Kurek M, Aughton DJ.
Familial medial telangiectatic nevus: variant of nevus fl ammeus—
port-wine stain. Plast Reconstr Surg 1993; 91: 1032-41.
56. Garzon MC, Enjolras O, Frieden IJ. Vascular tumors and vascular mal-
formations: evidence for an association. J Am Acad Dermatol 2000; 42:
275-9.
57. Leung AK, Telmesani AM. Salmon patches in Caucasian children.
Pediatr Dermatol 1989; 6: 185-7.
58. Juern AM, Glick ZR, Drolet BA, Frieden IJ. Nevus simplex: a reconsid-
eration of nomenclature, sites of involvement, and disease associa-
tions. J Am Acad Dermatol 2010; 63: 805-14.
59. Adams DM, Lucky AW. Cervicofacial vascular anomalies. I. Hemangio-
mas and other benign vascular tumors. Semin Pediatr Surg 2006; 15:
124-32.
60. Eubanks LE, McBurney EI. Videomicroscopy of port-wine stains: cor-
relation of location and depth of lesion. J Am Acad Dermatol 2001; 44:
948-51.
61. Eerola I, Boon LM, Mulliken JB, et al. Capillary malformation-
arteriovenous malformation, a new clinical and genetic disorder
caused by RASA1 mutations. Am J Hum Genet 2003; 73: 1240-9.
62. Hidai C, Zupancic T, Penta K, et al. Cloning and characterization of
developmental endothelial locus-1: an embryonic endothelial cell pro-
tein that binds the alphavbeta3 integrin receptor. Genes Dev 1998; 12:
21-33.
63. Stier MF, Glick SA, Hirsch RJ. Laser treatment of pediatric vascular
lesions: port wine stains and hemangiomas. J Am Acad Dermatol 2008;
58: 261-85.
64. McClean K, Hanke CW. The medical necessity for treatment of port-
wine stains. Dermatol Surg 1997; 23: 663-7.
65. Syed S, Weibel L, Kennedy H, Harper JI. A pilot study showing pulsed-
dye laser treatment improves localized areas of chronic atopic derma-
titis. Clin Exp Dermatol 2008; 33: 243-8.
66. Sidwell RU, Syed S, Harper JI. Port-wine stains and eczema. Br J Der-
matol 2001; 144: 1269-70.
67. Khaier A, Nischal KK, Espinosa M, Manoj B. Periocular port wine
stain: the great Ormond street hospital experience. Ophthalmology
2011; 118: 2274-2278, e2271.
68. Tallman B, Tan OT, Morelli JG, et al. Location of port-wine stains and
the likelihood of ophthalmic and/or central nervous system complica-
tions. Pediatrics 1991; 87: 323-7.
69. Comi AM, Bellamkonda S, Ferenc LM, Cohen BA, Germain-Lee EL.
Central hypothyroidism and Sturge-Weber syndrome. Pediatr Neurol
2008; 39: 58-62.
70. Tan E, Vinciullo C. Pulsed dye laser treatment of port-wine stains: a
review of patients treated in Western Australia. Med J Aust 1996; 164:
333-6.
71. Masclarelli P. Living with a port wine stain. In: Tan O, ed. Management
and Treatment of Benign Cutaneous Lesions. Philadelphia: Lea and
Febiger, 1992.
72. Schiffner R, Brunnberg S, Hohenleutner U, Stolz W, Landthaler M.
Willingness to pay and time trade-off: useful utility indicators for the
assessment of quality of life and patient satisfaction in patients with
port wine stains. Br J Dermatol 2002; 146: 440-7.
73. O'Donnell J, Sell S, Rauso L, Goode J. Undisclosed port-wine stain—
anesthetic implications and psychosocial considerations: a case report.
Aana J 2001; 69: 206-10.
74. Troilius A, Wrangsjo B, Ljunggren B. Patients with port-wine stains
and their psychosocial reactions after photothermolytic treatment.
Dermatol Surg 2000; 26: 190-6.
75. Augustin M, Zschocke I, Wiek K, Peschen M, Vanscheidt W. Psychoso-
cial stress of patients with port wine stains and expectations of dye
laser treatment. Dermatology 1998; 197: 353-60.
76. Troilius A, Wrangsjo B, Ljunggren B. Potential psychological benefi ts
from early treatment of port-wine stains in children. Br J Dermatol
1998; 139: 59-65.
77. Reyes BA, Geronemus R. Treatment of port-wine stains during child-
hood with the fl ashlamp-pumped pulsed dye laser. J Am Acad Derma-
tol 1990; 23: 1142-8.
78. Chapas AM, Eickhorst K, Geronemus RG. Effi cacy of early treatment
of facial port wine stains in newborns: a review of 49 cases. Lasers Surg
Med 2007; 39: 563-8.
79. Chapas AM, Geronemus RG. Our approach to pediatric dermatologic
laser surgery. Lasers Surg Med 2005; 37: 255-63.
80. Clodius L. Plastic surgery therapy of extensive port-wine stain of the
face. Schweiz Med Wochenschr 1983; 113: 274-80.
81. Clodius L. Surgery for the extensive facial port-wine stain? Aesthetic
Plast Surg 1985; 9: 61-8.
82. Clodius L. Surgery for the facial port-wine stain: technique and results.
Ann Plast Surg 1986; 16: 457-71.
83. Natkunarajah J, Cliff S. Thorium X treatment: multiple basal cell carci-
nomas within a port-wine stain. Clin Exp Dermatol 2009; 34: e189-91.
84. Hidano A, Ogihara Y. Cryotherapy with solid carbon dioxide in the
treatment of nevus fl ammeus. J Dermatol Surg Oncol 1977; 3: 213-16.
85. Wimmershoff MB, Schreyer AG, Glaessl A, et al. Mixed capillary/lym-
phatic malformation with coexisting port-wine stain: treatment utiliz-
ing 3D MRI and CT-guided sclerotherapy. Dermatol Surg 2000; 26:
584-7.
 
Search WWH ::




Custom Search